Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT01290263

Completed

Amgen 386 for Recurrent Glioblastoma

Glioblastoma Multiforme
NCT01976312

Completed

Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Central Retinal Vein Occlusion (CRVO) (Camellia)

Central Retinal Vein Occlusion
NCT00619684

Completed

Lenalidomide in Treating Patients With Progressive or Recurrent Multiple Myeloma After a Donor Stem Cell Transplant

Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple Myeloma
NCT01860586

Completed

Eye Injections of Bevacizumab for Lowering Risk of Scar Tissue in the Retina and Repeated Retinal Detachment.

Retinal Detachment | Vitreoretinopathy Proliferative
NCT01840683

Completed

HELP Therapy for Dry AMD (HELPuc)

Non-exudative (Dry) Age-related Macular Degeneration (AMD)
NCT00327171

Completed

Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancer

Neoplasms | Cancer of the Ovary
NCT00451906

Completed

A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.

Non-Squamous Non-Small Cell Lung Cancer
NCT00836355

Terminated

Enoxaparin and/or Minocycline in Acute Stroke

Acute Ischemic Stroke
NCT00000505

Completed

Thrombolysis in Myocardial Infarction (TIMI)

Myocardial Infarction | Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Disease
NCT01618474

Unknown

Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients

Stomach Cancer
NCT00224770

Completed

Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage Evacuation (MISTIE)

Intracerebral Hemorrhage
NCT00003107

Completed

Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors

Lymphoma | Kidney Cancer | Myelodysplastic Syndromes | Leukemia | Testicular Germ Cell Tumor | Breast Cancer | Chronic Myeloproliferative Disorders | Ovarian Cancer | Gestational Trophoblastic Tumor | Neuroblastoma
NCT00729638

Completed

RAD001 and Lenalidomide in the Treatment of Subjects With Relapsed and Relapsed/Refractory Multiple Myeloma

Multiple Myeloma
NCT00104962

Completed

Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes

Unspecified Childhood Solid Tumor, Protocol Specific | Childhood Myelodysplastic Syndromes | Previously Treated Myelodysplastic Syndromes | Secondary Myelodysplastic Syndromes | de Novo Myelodysplastic Syndromes | Refractory Anemia | Refractory Anemia With Excess Blasts | Refractory Cytopenia With Multilineage Dysplasia | Refractory Anemia With Ringed Sideroblasts
NCT00694382

Completed

Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy (SAVE-ONCO)

Cancer | Venous Thromboembolism
NCT00396591

Completed

AVE0005 (VEGF Trap) in Patients With Recurrent Symptomatic Malignant Ascites

Ovarian Neoplasms
NCT00284141

Completed

Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma

Neoplasms, Lung | Pulmonary Diseases
NCT00912119

Completed

Amicar Pharmacokinetics of Children Having Craniofacial Surgery

Craniosynostosis
NCT00211458

Completed

Treatment of Age-Related Macular Degeneration With Anecortave Acetate

Macular Degeneration
NCT01131585

Terminated

Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RELATION)

Visual Impairment Due to Diabetic Macular Edema
NCT01372761

Completed

Pharmacokinetics, Safety, Tolerability and Efficacy of Intravenous Doses of ZGN-433 in Obese Female Volunteers

Obesity
NCT01060163

Completed

Tranexamic Acid in Clopidogrel Exposure to Decrease Hemorrhage and Transfusion (TRACED)

Coronary Artery Disease
NCT01029821

Unknown

Low-Molecular-Weight Heparin (LMWH) for Deep Venous Thrombosis (DVT) Prophylaxis

Deep Venous Thrombosis
NCT01017107

Completed

Activated Protein C in Severe Acute Pancreatitis

Acute Pancreatitis
NCT01031992

Completed

Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) (TAHHT)

Hereditary Hemorrhagic Telangiectasia
NCT01027481

Completed

Ranibizumab in Patients With Branch Retinal Vein Occlusion

Retinal Vein Occlusion
NCT00885300

Completed

Cloxacillin as Prevention of Double Lumen Infection in Hemodialysis Patients

Hemodialysis | Double Lumen Infection
NCT00279578

Completed

Clot Formation and Clot Stability in Patients With Severe Haemophilia A

Hemophilia A
NCT06152822

Recruiting

Pyrotinib Combined With Capecitabine and Bevacizumab for Patients With HER2 Positive Breast Cancer and Brain Metastases

Breast Cancer With Brain Metastases
NCT05173298

Recruiting

Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab (HCC)

Advanced Hepatocellular Carcinoma
NCT04659382

Recruiting

Study to Evaluate Efficacy and Safety of Selective Internal Radiation Therapy Plus Xelox, Bevacizumab and Atezolizumab (Immune Chekpoint Inhibitor) in Patients With Liver-dominant Metastatic Colorectal Cancer (SIRTCI)

Metastatic Colorectal Cancer | MSS | pMMR | Immune Checkpoint Inhibitor | Internal Radiotherapy
NCT06490055

Completed

Predicting the Efficacy in Advanced Gastric Cancer.

Gastric Cancer | Chemotherapy Effect | Ramucirumab | Paclitaxel
NCT02724878

Completed

Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma

Advanced Non-Clear Cell Kidney Cancer
NCT06006286

Withdrawn

A Study Evaluating Atezolizumab and Bevacizumab Plus ADI-PEG 20 in Patients With Locally Advanced / Metastatic Hepatocellular Carcinoma

Metastatic Hepatocellular Carcinoma
NCT01241786

Terminated

Study Examining the Combination of Revlimid (Lenalidomide)and Vidaza (Azacitidine) for Relapsed/Refractory CLL and SLL (VZCLLPI0146)

Small Lymphocytic Lymphoma | Chronic Lymphocytic Leukemia(CLL)
NCT02164240

Completed

Phase Ib Study of SUnitinib Alternating With REgorafenib in Patients With Metastatic and/or Unresectable GIST (SURE)

Gastrointestinal Stromal Tumor
NCT02570789

Terminated

Evaluation of Predictive Markers for Toxicity and Efficacy in Patients With mccRCC Treated by Anti-VEGF Therapy (METASUN)

Clear-cell Metastatic Renal Cell Carcinoma
NCT01673386

Terminated

A Subject Treatment Preference Study of Tivozanib Versus Sunitinib in Subjects With Metastatic RCC (TAURUS)

Metastatic Renal Cell Carcinoma
NCT02239952

Unknown

HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors)

Cancer | High-grade Glioma
NCT04511715

Unknown

Intravitreal Bevacizumab for Nonproliferative Diabetic Retinopathy

Non-proliferative Diabetic Retinopathy
NCT02402062

Completed

A Study to Assess the Safety and the Efficacy of the Combination of TH-302 and Sunitinib in Neuroendocrine Pancreatic Tumours

Pancreatic Neoplasms | Neuroendocrine Tumors
NCT04063449

Unknown

Endostar/PD-1 Inhibitors Combined With PP for Advanced NSCLC

Non-squamous Non-small Cell Lung Cancer
NCT02610153

Completed

Subtherapeutic INR Levels in Patients With AVK: Incidence, Associated Factors, Prognosis and Control Strategies (SULTAN)

Atrial Fibrillation
NCT01258348

Completed

A Phase 1b Trial in Patients With Renal Cell Cancer

Metastatic Renal Cell Cancer
NCT00451048

Completed

Sunitinib in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Secondary Myelodysplastic Syndromes | de Novo Myelodysplastic Syndromes
NCT01582672

Terminated

Phase 3 Trial of Autologous Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Renal Cell Carcinoma | Metastatic Renal Cell Carcinoma | Advanced Renal Cell Carcinoma
NCT00632541

Terminated

A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer

Metastatic Breast Cancer
NCT02737670

Completed

Sulodexide Efficacy in Chronic Idiopathic Subjective Tinnitus (SECIST)

Tinnitus, Subjective
NCT02472574

Unknown

Dose-effect Relationship of Rt-PA on ICH Evacuation

Hypertensive Intracerebral Hemorrhage
NCT00990158

Completed

Does Low Dose Oral Vitamin K Improve International Normalized Ratio (INR) Stability? (OVWAC VII)

Thrombosis | Bleeding | Coagulation

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations